306 related articles for article (PubMed ID: 22426264)
21. Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?
Zih FS; Wong-Chong N; Hummel C; Petronis J; Panzarella T; Pollett A; McCart JA; Swallow CJ
Ann Surg Oncol; 2014 Jan; 21(1):225-31. PubMed ID: 24100959
[TBL] [Abstract][Full Text] [Related]
22. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
Mahteme H; Sugarbaker PH
Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
[TBL] [Abstract][Full Text] [Related]
23. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.
Pallas N; Karamveri C; Kyziridis D; Hristakis C; Kyriakopoulos V; Kalakonas A; Vaikos D; Tentes AK
J BUON; 2017; 22(6):1547-1553. PubMed ID: 29332351
[TBL] [Abstract][Full Text] [Related]
25. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
26. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
27. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Iavazzo C; Spiliotis J
Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
[No Abstract] [Full Text] [Related]
28. Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients.
Chua TC; Al-Alem I; Saxena A; Liauw W; Morris DL
Ann Surg Oncol; 2011 Jun; 18(6):1540-6. PubMed ID: 21491165
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
Marcotte E; Sideris L; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Dubé P
Ann Surg Oncol; 2008 Oct; 15(10):2701-8. PubMed ID: 18654822
[TBL] [Abstract][Full Text] [Related]
30. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination.
Mohamed F; Chang D; Sugarbaker PH
J Surg Oncol; 2003 May; 83(1):5-12; discussion 12-3. PubMed ID: 12722090
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
[TBL] [Abstract][Full Text] [Related]
32. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
Munoz-Zuluaga CA; King MC; Ledakis P; Gushchin V; Sittig M; Nieroda C; Zambrano-Vera K; Sardi A
Eur J Surg Oncol; 2019 Sep; 45(9):1598-1606. PubMed ID: 31109821
[TBL] [Abstract][Full Text] [Related]
33. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
Milovanov V; Sardi A; Ledakis P; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641
[TBL] [Abstract][Full Text] [Related]
34. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy.
Glehen O; Mohamed F; Sugarbaker PH
Ann Surg; 2004 Aug; 240(2):278-85. PubMed ID: 15273552
[TBL] [Abstract][Full Text] [Related]
35. Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Alshammari T; Alshammari S; Hakami R; Alharbi A; Alyami M; Abdulla M; Bin Traiki T
Am J Case Rep; 2019 Nov; 20():1648-1651. PubMed ID: 31704906
[TBL] [Abstract][Full Text] [Related]
36. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.
Sugarbaker PH; Chang D
Ann Surg Oncol; 1999 Dec; 6(8):727-31. PubMed ID: 10622499
[TBL] [Abstract][Full Text] [Related]
37. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.
Austin F; Mavanur A; Sathaiah M; Steel J; Lenzner D; Ramalingam L; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2012 May; 19(5):1386-93. PubMed ID: 22302270
[TBL] [Abstract][Full Text] [Related]
38. Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
Liberale G; Elias D; Sideris L; Lasser P; Malka D; Sabourin JC; Pocard M
J Surg Oncol; 2005 Jul; 91(1):73-6. PubMed ID: 15999360
[TBL] [Abstract][Full Text] [Related]
39. Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.
Ward EP; Okamuro L; Khan S; Hosseini M; Valasek MA; Ronquillo N; Kelly KJ; Veerapong J; Lowy AM; Baumgartner J
Hum Pathol; 2021 Jul; 113():104-110. PubMed ID: 33905776
[TBL] [Abstract][Full Text] [Related]
40. Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination.
Huang Y; Alzahrani NA; Liauw W; Soudy H; Alzahrani AM; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2292-2298. PubMed ID: 29017824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
